Empire

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – DOMA, LABP, FUSN, CBNK

Retrieved on: 
Tuesday, April 9, 2024

NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.

Key Points: 
  • NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.
  • Under the terms of the agreement, DOMA shareholders are expected to receive $6.29 in cash per share they own.
  • Capital Bancorp, Inc. (Nasdaq: CBNK ), relating to its proposed merger with Integrated Financial Holdings, Inc.
  • Under the terms of the agreement, CBNK shareholders are estimated to receive $5.36 in cash and 1.115 shares of Capital common stock per share they own.

TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger – NS, CTLT, SCX, EVBG

Retrieved on: 
Thursday, April 4, 2024

Under the terms of the agreement, NS shareholders are expected to receive 0.4 shares of Sunoco per share they own.

Key Points: 
  • Under the terms of the agreement, NS shareholders are expected to receive 0.4 shares of Sunoco per share they own.
  • Under the terms of the agreement, CTLT shareholders will receive $63.50 in cash per share they own.
  • Under the terms of the agreement, EVBG shareholders will receive $28.60 in cash per share they own.
  • Before you hire a law firm, you should talk to a lawyer and ask:
    Do you file class actions and go to Court?

Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

Retrieved on: 
Thursday, April 4, 2024

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE : The National Infertility Association today announced a series of nationwide events to commemorate National Infertility Awareness Week (April 21-27, 2024).

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE : The National Infertility Association today announced a series of nationwide events to commemorate National Infertility Awareness Week (April 21-27, 2024).
  • "National Infertility Awareness Week sheds light on the profound impact of infertility, promoting compassion, empathy, and solidarity for the countless individuals struggling to build their family," said Pete Anevski, CEO of Progyny.
  • This will be the third consecutive year the Empire State Building will be lit to support those faced with infertility.
  • "Being an advocate for others navigating their journey, I am deeply honored to participate in National Infertility Awareness Week alongside Progyny and RESOLVE,” says Iskra Lawrence.

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

Retrieved on: 
Tuesday, April 2, 2024

WATERTOWN, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced the appointment of leading global ophthalmologists to its Scientific Advisory Board (SAB), co-chaired by Carl Regillo M.D., FACS, Chief of the Retina Service at Wills Eye Hospital and Charles Wykoff, M.D., Ph.D., Director of Research of Retina Consultants of Texas. The SAB additions include Usha Chakravarthy, M.B.B.S., Ph.D.; Allen Ho, M.D. FACS FASRS, and Frank Holz, M.D., F.E.B.O., F.A.R.V.O. These three world-renowned retinal specialists will support advancement of the Company’s global clinical strategy ahead of the anticipated initiation of its Phase 3 pivotal trials in wet age-related macular degeneration (wet AMD) in the second half of this year. Additionally, the Company announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the trade name, DURAVYUTM (vorolanib intravitreal insert) for the Company’s lead product candidate, EYP-1901.

Key Points: 
  • “The SAB’s strategic counsel, global expertise, and scientific knowledge will be incredibly valuable during this critical time in EyePoint’s growth and expansion.
  • Dr. Chakravarthy has authored or co-authored over 400 publications, and she is invited to lecture in the UK and abroad.
  • FACS FASRS is Attending Surgeon, Director of Retina Research and Co-Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.
  • He is a Board Member of the German Ophthalmological Society, and of the Club Jules Gonin and is past president of EURETINA.

Monteverde & Associates PC Reminds Former RealNetworks Investors of Upcoming May 3, 2024 Deadline to Lead Federal Class Action

Retrieved on: 
Monday, March 25, 2024

Under the terms of the Merger, each share of RealNetworks common stock owned cashed out for $0.73 per share (the “Merger Consideration”).

Key Points: 
  • Under the terms of the Merger, each share of RealNetworks common stock owned cashed out for $0.73 per share (the “Merger Consideration”).
  • Mr. Juan Monteverde is available to personally discuss this case with you, and if you wish to serve as lead plaintiff, you must seek lead appointment in the Federal Class Action no later than May 3, 2024.
  • At Monteverde & Associates PC, our firm litigates and has recovered money for shareholders… and we do it from our offices in the Empire State Building.
  • We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.

Titan Reports 16% Increase in Production While Lowering Costs

Retrieved on: 
Friday, March 22, 2024

Deepening of the lower Mahler ramp system provided access to high-grade ore in the Lower Mahler mining zone that supported strong grades and record metal production.

Key Points: 
  • Deepening of the lower Mahler ramp system provided access to high-grade ore in the Lower Mahler mining zone that supported strong grades and record metal production.
  • It is expected that ore from this zone will continue to support budgeted zinc grades for FY2024.
  • Major projects completed include the counter-weight rail replacement for the service cage and purchase of a telehandler for underground material movement.
  • A total of 7,984 ft was drilled, with mineralization intercepted 600 ft down dip from the current active faces of Lower Mahler.

Jonathan Roumie of “The Chosen” to be Catholic University’s 2024 Commencement Speaker

Retrieved on: 
Wednesday, March 20, 2024

Washington, D. C., March 20, 2024 (GLOBE NEWSWIRE) -- Award-winning actor Jonathan Roumie of “The Chosen,” will serve as the commencement speaker for The Catholic University of America’s 2024 graduation ceremony held on Saturday, May 11, 2024.

Key Points: 
  • Washington, D. C., March 20, 2024 (GLOBE NEWSWIRE) -- Award-winning actor Jonathan Roumie of “The Chosen,” will serve as the commencement speaker for The Catholic University of America’s 2024 graduation ceremony held on Saturday, May 11, 2024.
  • Roumie also starred in the 2023 movie, “Jesus Revolution.”
    In addition to his work as an actor, Roumie is actively involved with his Catholic faith.
  • Catholic media have recognized him as a leader of the faith, with Our Sunday Visitor naming Roumie to a list of Catholics of the Year in 2022.
  • The Commencement ceremony will be held on the steps of the Basilica of the National Shrine of the Immaculate Conception.

INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – TGAN, HMST, KNTE

Retrieved on: 
Monday, March 18, 2024

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.

Key Points: 
  • NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.
  • Under the terms of the agreement, TGAN shareholders will receive $5.10 in cash per share they own.
  • Under the terms of the agreement, HMST shareholders are expected to receive 0.4345 shares of FirstSun common stock per share they own.
  • Before you hire a law firm, you should talk to a lawyer and ask:
    Do you recover money for shareholders?

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – DOOR, FREE, INBX, TAST

Retrieved on: 
Monday, March 18, 2024

Under the terms of the agreement, DOOR shareholders are expected to receive $133.00 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, DOOR shareholders are expected to receive $133.00 in cash per share they own.
  • Under the terms of the agreement, FREE shareholders are expected to receive $4.875 in cash per share they own.
  • Under the terms of the agreement, TAST shareholders are expected to receive $9.55 in cash per share they own.
  • Before you hire a law firm, you should talk to a lawyer and ask:
    Do you recover money for shareholders?

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – KAMN, EVBG, JNPR, HAYN

Retrieved on: 
Monday, March 18, 2024

Under the terms of the agreement, KAMN shareholders are expected to receive $46.00 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, KAMN shareholders are expected to receive $46.00 in cash per share they own.
  • Under the terms of the agreement, EVBG shareholders will receive $28.60 in cash per share they own.
  • Under the terms of the agreement, HAYN shareholders will receive $61.00 in cash per share they own.
  • Before you hire a law firm, you should talk to a lawyer and ask:
    Do you recover money for shareholders?